Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding

Chronic pain is a prevalent problem affecting approximately one out of every five adults in the U.S. The most effective way to treat chronic pain is with opioids, but they cause dangerous side effects such as tolerance, addiction, and respiratory depression, which makes them quite deadly. Opioids, such as fentanyl, target the μ-opioid receptor (MOR), which can then bind to the intracellular G<sub>i</sub> protein or the β-arrestin protein. The G<sub>i</sub> pathway is primarily responsible for pain relief and potential side effects, but the β-arrestin pathway is chiefly responsible for the unwanted side effects. Ideally, an effective pain medication without side effects would bind to MOR, which would bias signaling solely through the G<sub>i</sub> pathway. We used the Bio3D library to conduct principal component analysis to compare the cryo-electron microscopy MOR structure in complex with the G<sub>i</sub> versus an X-ray crystallography MOR structure with a nanobody acting as a G<sub>i</sub> mimic. Our results agree with a previous study by Munro, which concluded that nanobody-bound MOR is structurally different than G<sub>i</sub>-bound MOR. Furthermore, we investigated the structural diversity of opioids that can bind to MOR. Quantum mechanical calculations show that the low energy solution structures of fentanyl differ from the one bound to MOR in the experimental structure, and p<i>K</i><sub>a</sub> calculations reveal that fentanyl is protonated in aqueous solution. Glide docking studies show that higher energy structures of fentanyl in solution form favorable docking complexes with MOR. Our calculations show the relative abundance of each fentanyl conformation in solution as well as the energetic barriers that need to be overcome to bind to MOR. Docking studies confirm that multiple fentanyl conformations can bind to the receptor. Perhaps a variety of conformations of fentanyl can stabilize multiple conformations of the MOR, which can explain why fentanyl can induce different intracellular signaling and multiple physiological effects.

Authors

Institutions

Publication Details

Journal
The Journal of Physical Chemistry B
Published
2024-12-19
DOI
https://doi.org/10.1021/acs.jpcb.4c05214
Citations
5
Primary Topic
Receptor Mechanisms and Signaling
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding

Lynne A. Jones, João Batista Teixeira da Rocha, George C. Shields, Leah A. Juechter et al.
5 citations
The Journal of Physical Chemistry B
Receptor Mechanisms and Signaling
1.17
article

Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding

Lynne A. Jones, João Batista Teixeira da Rocha, George C. Shields, Leah A. Juechter, Caitlin E. Scott, Brenna Outten, Taylor D. Aishman, Alaina R. Ivers
article en
5 citations

Abstract

Chronic pain is a prevalent problem affecting approximately one out of every five adults in the U.S. The most effective way to treat chronic pain is with opioids, but they cause dangerous side effects such as tolerance, addiction, and respiratory depression, which makes them quite deadly. Opioids, such as fentanyl, target the μ-opioid receptor (MOR), which can then bind to the intracellular G<sub>i</sub> protein or the β-arrestin protein. The G<sub>i</sub> pathway is primarily responsible for pain relief and potential side effects, but the β-arrestin pathway is chiefly responsible for the unwanted side effects. Ideally, an effective pain medication without side effects would bind to MOR, which would bias signaling solely through the G<sub>i</sub> pathway. We used the Bio3D library to conduct principal component analysis to compare the cryo-electron microscopy MOR structure in complex with the G<sub>i</sub> versus an X-ray crystallography MOR structure with a nanobody acting as a G<sub>i</sub> mimic. Our results agree with a previous study by Munro, which concluded that nanobody-bound MOR is structurally different than G<sub>i</sub>-bound MOR. Furthermore, we investigated the structural diversity of opioids that can bind to MOR. Quantum mechanical calculations show that the low energy solution structures of fentanyl differ from the one bound to MOR in the experimental structure, and p<i>K</i><sub>a</sub> calculations reveal that fentanyl is protonated in aqueous solution. Glide docking studies show that higher energy structures of fentanyl in solution form favorable docking complexes with MOR. Our calculations show the relative abundance of each fentanyl conformation in solution as well as the energetic barriers that need to be overcome to bind to MOR. Docking studies confirm that multiple fentanyl conformations can bind to the receptor. Perhaps a variety of conformations of fentanyl can stabilize multiple conformations of the MOR, which can explain why fentanyl can induce different intracellular signaling and multiple physiological effects.

The Journal of Physical Chemistry BVol. 129(1)
Hendrix College (US), California State University Los Angeles (US), Conway School of Landscape Design (US), Furman University (US)
Research Corporation for Science Advancement, National Institute of General Medical Sciences, Office of Advanced Cyberinfrastructure, Division of Computer and Network Systems, Division of Chemistry
Zero hunger
Openalex Percentile: Top 21%
Receptor Mechanisms and Signaling
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.